Search
for
Sort by
Research 31–60 of 192
- Cutaneous manifestations of systemic infection in children
- Nutritional Clinical Studies in Dermatology
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Atlas of Geriatric Dermatology
- Chronic graft versus host disease and skin
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Rare Cutaneous Side Effects of Imiquimod: A Review on Its Mechanisms, Diagnosis, and Management
- Adult Kawasaki's disease with myocarditis, splenomegaly, and highly elevated serum ferritin levels
- Skin, mucosa and nail findings in hospitalized pediatric patients with Coronavirus disease-2019 (COVID-19)
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Laser-Assisted Drug Delivery: A Systematic Review of Safety and Adverse Events
- Prophylaxis and Management of Skin Toxicities
- Skin manifestations associated with systemic diseases – Part I
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- The Nutrient–Skin Connection: Diagnosing Eating Disorders Through Dermatologic Signs
- Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review
- Rare and common manifestations of COVID‐19 in children
- Periungual lesions secondary to chemotherapy with docetaxel
- The spectrum of cutaneous manifestations in lupus erythematosus—the Italian experience
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Telecommunication in the COVID-19 era: As an assessment tool for patients with dermatomyositis
- Standardized classification tools in dermatology: time to focus on cutaneous warts
- THERAPEUTIC CHALLENGES IN POLYAUTOIMMUNITY: ANIFROLUMAB FOR LUPUS ERYTHEMATODES IN OVERLAPPING AUTOIMMUNE SYNDROMES
- Therapeutic Response of Alopecia Areata‐Associated Nail Changes to Baricitinib
- Abstract 2469: Increased cathepsin B expression in cultured tuberous sclerosis skin tumor cells and patient tumor tissues
- A case report of verruca vulgaris on basis of alopecia areata successfully treated with diphenylcyclopropenone